• Apr 23, 2025

CEO gloom rivals financial crisis as tariffs hit S&P 500 stocks

(Bloomberg) -- Not since the financial crisis has Corporate America been so downbeat about the state of the economy in earnings calls, an ominous sign for investors trying to figure out how much more pain Donald Trump’s trade war will inflict on the stock market.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeDOGE Visits National Gallery of Art to Discuss Museum’s Legal StatusThe Racial Wealth Gap Is Not Just About MoneyBackyard Micro-Flats Aim to Ease South A

• Apr 23, 2025

3 Reasons RUN is Risky and 1 Stock to Buy Instead

Sunrun’s stock price has taken a beating over the past six months, shedding 50.7% of its value and falling to $6.83 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

• Apr 23, 2025

3 Reasons to Sell BRC and 1 Stock to Buy Instead

Brady trades at $68.82 per share and has stayed right on track with the overall market, losing 6% over the last six months while the S&P 500 is down 6.9%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

• Apr 23, 2025

3 Reasons CGNX is Risky and 1 Stock to Buy Instead

Cognex has gotten torched over the last six months - since October 2024, its stock price has dropped 35.6% to $24.96 per share. This may have investors wondering how to approach the situation.

• Apr 23, 2025

3 Reasons to Avoid CCOI and 1 Stock to Buy Instead

Cogent’s stock price has taken a beating over the past six months, shedding 36.5% of its value and falling to $52.28 per share. This might have investors contemplating their next move.

• Apr 23, 2025

3 Reasons to Sell GDRX and 1 Stock to Buy Instead

GoodRx’s stock price has taken a beating over the past six months, shedding 30.4% of its value and falling to $4.55 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

• Apr 23, 2025

3 Reasons to Sell MLKN and 1 Stock to Buy Instead

What a brutal six months it’s been for MillerKnoll. The stock has dropped 29.8% and now trades at $16.66, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

• Apr 23, 2025

3 Reasons to Avoid MEC and 1 Stock to Buy Instead

Mayville Engineering has gotten torched over the last six months - since October 2024, its stock price has dropped 34.2% to $13 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

• Apr 23, 2025

3 Reasons to Avoid SKIN and 1 Stock to Buy Instead

Shareholders of BeautyHealth would probably like to forget the past six months even happened. The stock dropped 46.5% and now trades at $0.89. This may have investors wondering how to approach the situation.

• Apr 23, 2025

3 Reasons PPC is Risky and 1 Stock to Buy Instead

Since April 2020, the S&P 500 has delivered a total return of 92.8%. But one standout stock has nearly doubled the market - over the past five years, Pilgrim's Pride has surged 177% to $55.20 per share. Its momentum hasn’t stopped as it’s also gained 20.4% in the last six months, beating the S&P by 27.3%.